Scientist are racing to develop new tools to combat and treat COVID-19. One of those tools is an experimental pill to treat the pandemic.
Merck is the first company to seek emergency us authorization from the FDA with its molnupiravir, an antiviral pill which, once approved, will become a valuable tool in the fight to end the COVID-19 pandemic. The company made this announcement on Friday.
Please subscribe to our newsletter… https://tnc.network/newsletter/
Rod is a blogger, writer, filmmaker, photographer, daydreamer who likes to cook. Rod produces and directs the web series, CUPIC: Diary of an Investigator. He is also the editor, producer and administrator of TNC Network.